e-Therapeutics plc TR-1: Notification of Major Interest in Shares (0578H)
03 June 2017 - 12:19AM
UK Regulatory
TIDMETX TIDMAV.
RNS Number : 0578H
e-Therapeutics plc
02 June 2017
For filings with the FCA
include the annex
For filings with issuer exclude
the annex
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i)
-----------------------------------------------------------------------------------------------------
1. Identity of the issuer or e-Therapeutics plc
the underlying issuer
of existing shares to which
voting rights are
attached: (ii)
----------------------------------------------------------------- ----------------------------------
2 Reason for the notification (please tick the appropriate
box or boxes):
-----------------------------------------------------------------------------------------------------
An acquisition or disposal of voting rights
-------------------------------------------------------------------- -------------------------------
An acquisition or disposal of qualifying financial
instruments which may result in the acquisition
of shares already issued to which voting rights
are attached
-------------------------------------------------------------------- -------------------------------
An acquisition or disposal of instruments with
similar economic effect to qualifying financial
instruments
-------------------------------------------------------------------- -------------------------------
An event changing the breakdown of voting rights
-------------------------------------------------------------------- -------------------------------
Other (please
specify):
----------------------------------------------------------- ------- -------------------------------
3. Full name of person(s) Aviva plc & its subsidiaries
subject to the
notification obligation:
(iii)
------------------------------------------------------------- --------------------------------------
4. Full name of shareholder(s) N/A
(if different from 3.):(iv)
------------------------------------------------------------- --------------------------------------
5. Date of the transaction 01 June 2017
and date on
which the threshold is
crossed or
reached: (v)
------------------------------------------------------------- --------------------------------------
6. Date on which issuer 02 June 2017
notified:
------------------------------------------------------------- --------------------------------------
7. Threshold(s) that is/are 15% to <5% Change at Combined
crossed or Interest Level AND 15% to
reached: (vi, vii) <3% Change at Direct Interest
Level
------------------------------------------------------------- --------------------------------------
8. Notified details:
--------------------------------------------------------------------------------------------------------------
A: Voting rights attached to shares (viii, ix)
--------------------------------------------------------------------------------------------------------------
Class/type Situation previous Resulting situation after the
of to the triggering triggering transaction
shares transaction
if possible
using
the ISIN
CODE
-------------------- -------------------------------- ------------------------------------------------------
Number Number Number Number of % of voting
of of of shares voting rights (x)
Shares Voting rights
Rights
-------------------- ------------------- ----------- ------------ ------------------- -------------------
Direct Direct Indirect Direct Indirect
(xi) (xii)
-------------------- ------------------- ----------- ------------ ------- ---------- ------- ----------
Ordinary
Shares
GB00B2823H99 42,542,868 42,542,868 Nil Nil Nil Nil Nil
------------------- ----------- ------------ ------- ---------- ------- ----------
B: Qualifying Financial Instruments
--------------------------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
--------------------------------------------------------------------------------------------------------------
Type of financial Expiration Exercise/ Number of voting % of voting
instrument date Conversion rights that rights
(xiii) Period (xiv) may be
acquired if
the
instrument
is
exercised/
converted.
-------------------- ------------------- ------------------------- ------------------- -------------------
C: Financial Instruments with similar economic effect
to Qualifying Financial Instruments (xv, xvi)
-----------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
-----------------------------------------------------------------------------------------------
Type of financial Exercise Expiration Exercise/ Number of voting % of voting
instrument price date Conversion rights instrument rights (xix,
(xvii) period refers to xx)
(xviii)
------------------ --------- ----------- ------------ ------------------- ----------------
Nominal Delta
------------------ --------- ----------- ------------ ------------------- -------- ------
Total (A+B+C)
-------------------------------------------------------
Number of voting rights Percentage of voting rights
------------------------- ----------------------------
Nil 0%
------------------------- ----------------------------
9. Chain of controlled undertakings through which the
voting rights and/or the
financial instruments are effectively held, if applicable:
(xxi)
--------------------------------------------------------------------------
Proxy Voting:
--------------------------------------------------------------------------
10. Name of the proxy holder: See Section 4
--------------------------------------------- ---------------------------
11. Number of voting rights proxy
holder will cease to hold:
--------------------------------------------- ---------------------------
12. Date on which proxy holder will
cease to hold voting rights:
--------------------------------------------- ---------------------------
13. Additional information:
--------------------------------------------- ---------------------------
14. Contact name: Michael Dunhill, Aviva plc
--------------------------------------------- ---------------------------
15. Contact telephone number: 01603 685988
--------------------------------------------- ---------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLLLFLSRRIFIID
(END) Dow Jones Newswires
June 02, 2017 10:19 ET (14:19 GMT)
E-therapeutics (LSE:ETX)
Historical Stock Chart
From Apr 2024 to May 2024
E-therapeutics (LSE:ETX)
Historical Stock Chart
From May 2023 to May 2024
